TipHub

508.5

+0.46 +0.09%

As of 28 Jul 2026 · delayed

NSE Listed · Healthcare

Indegene Limited (INDGN)

Volume: 1,13,363Avg Vol 1W: 1,20,790Avg Vol 1M: 1,76,48752W Range:414596.8
Market Cap₹12,250 Cr
Current Price₹508.5
Previous Close₹508.04
High / Low (52w)₹596.8 / ₹414
Volume1,13,363
Avg Vol (1W)1,20,790
Avg Vol (1M)1,76,487
Stock P/E153.16
Book Value₹130.51
Dividend Yield0.44%
ROE12.78%
ROA8.68%
Revenue (TTM)
Revenue Growth9.64%
Profit Margin11.43%
Total Debt₹0 Cr
Shares Outstanding24 Cr
Face Value₹2
EPS (TTM)₹3.32
P/B3.9
Debt / Equity0.05
50 DMA₹512.67
200 DMA₹505.48
Day change+0.09%
Price Chart
508.5 7.35% · 1Y
59742454.7L
2025-07-29
2026-07-28

20-day avg volume: 1.8L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 873% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 153.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹677 Cr₹687 Cr₹720 Cr₹756 Cr₹761 Cr₹804 Cr₹942 Cr₹1,003 Cr
EBITDA₹131 Cr₹128 Cr₹150 Cr₹152 Cr₹156 Cr₹137 Cr₹139 Cr₹133 Cr
Net Profit₹88 Cr₹92 Cr₹110 Cr₹118 Cr₹116 Cr₹102 Cr₹103 Cr₹80 Cr
EPS
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026
Revenue₹287 Cr₹267 Cr₹2,947 Cr₹256 Cr₹307 Cr₹290 Cr₹3,583 Cr₹368 Cr
EBITDA₹68 Cr₹68 Cr₹561 Cr₹62 Cr₹80 Cr₹51 Cr₹565 Cr₹98 Cr
Net Profit₹50 Cr₹54 Cr₹407 Cr₹45 Cr₹60 Cr₹35 Cr₹401 Cr₹72 Cr
EPS17.0216.62
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹329 Cr₹600 Cr₹596 Cr₹1,353 Cr₹2,204 Cr₹2,546 Cr₹3,326 Cr₹4,620 Cr
Total Liabilities₹177 Cr₹616 Cr₹263 Cr₹590 Cr₹1,140 Cr₹1,117 Cr₹710 Cr₹1,482 Cr
Equity₹152 Cr₹-16 Cr₹333 Cr₹764 Cr₹1,064 Cr₹1,429 Cr₹2,616 Cr₹3,139 Cr
Total Debt
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹82 Cr₹49 Cr₹222 Cr₹367 Cr₹238 Cr₹633 Cr₹602 Cr₹798 Cr
Investing₹-19 Cr₹-18 Cr₹-24 Cr₹-160 Cr₹-893 Cr₹-327 Cr₹-683 Cr₹-512 Cr
Financing₹-21 Cr₹136 Cr₹-132 Cr₹233 Cr₹333 Cr₹-66 Cr₹288 Cr₹-83 Cr
Free Cash Flow₹82 Cr₹49 Cr₹222 Cr₹367 Cr₹238 Cr₹633 Cr₹602 Cr₹798 Cr
Shareholding
Promoter 0% Institutions 18.66% Public 81.34%
Efficiency & Working Capital
ROCE15.6%
Interest Coverage28.2
Dividend Payout
Debtor Days97 d
Inventory Days0 d
Payable Days12 d
Cash Conversion Cycle85 d
Working Capital Days97 d
Shareholding Details

As of 2026-06-30

Promoter0%
FII9.9%
DII8.7%
Institutions18.7%
Public81.3%
Promoter Pledge
No. of Shareholders1,38,533
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodApr 2024May 2024May 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters0%0%0%0%0%0%0%0%0%0%0%0%
FIIs0%3.6%3.6%3.8%4.8%5%5.2%10%11.3%11.5%10.3%9.9%
DIIs0%5.3%3.9%3.8%3.2%4%5%7.2%7%8.1%8.3%8.7%
Public100%90.8%92.6%92.4%92%91%89.8%82.7%81.7%80.4%81.4%81.3%
Promoter Pledge0%0%0%0%0%0%0%0%0%
No. of Shareholders824,43,7854,43,7852,03,5991,51,4401,53,7891,44,7081,51,9971,51,8091,47,1821,42,1191,38,533
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Nadathur Fareast Pte LtdPublic Shareholding21.9%5.27 Cr
Manish GuptaPublic Shareholding8.9%2.15 Cr
Rajesh Bhaskaran NairPublic Shareholding7.1%1.72 Cr
Bpc Genesis Fund I Spv LtdPublic Shareholding5.8%1.39 Cr
Sanjay S ParikhPublic Shareholding5%1.20 Cr
Bpc Genesis Fund I A Spv LtdPublic Shareholding3%71,90,255
Gaurav KapoorPublic Shareholding2.6%62,66,736
Government Pension Fund GlobalPublic Shareholding2.6%62,00,000
Vida Trustees Private LimitedPublic Shareholding2.3%55,88,802
Anand KiranPublic Shareholding2.2%52,11,360
Aarabhi Partners Consultants LlpPublic Shareholding2.1%50,40,000
Sundaram Mutual Fund A/c Sundaram Mid Cap FundPublic Shareholding1.9%45,80,721
Fidelity Funds - India Focus FundPublic Shareholding1.5%36,02,637
Chestnut Associates Ptc LimitedPublic Shareholding1.4%34,39,800
Sycamore Philanthropy (ptc) LimitedPublic Shareholding1.4%34,39,800
Smallcap World Fund, IncPublic Shareholding1.4%34,11,405
Sbi Innovative Opportunities FundPublic Shareholding1.3%30,67,330
Icici Prudential Technology FundPublic Shareholding1.2%28,63,997
Board of Directors
NameDesignationYear
Manish GuptaChairman & Executive Director2025
Sanjay Suresh ParikhDirector & Executive Vice President2025
Krishnamurthy Venugopala TennetiIndependent Director2025
Ashish GuptaIndependent Director2025
Jairaj Manohar PurandareIndependent Director2025
U B Pravin RaoIndependent Director2025
Georgia Nikolakopoulou PapathomasIndependent Director2025
Rajesh Bhaskaran NairNon Executive Director2025
Neeraj BharadwajNon Executive Director2025
Mark Francis DzialgaNominee2025
Srishti Ramesh Kaushik..Company Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Pharma Marketing Services₹0 Cr
Segments — Geography
RegionRevenueShare
North America₹1,060 Cr86.8%
Europe₹134 Cr11%
India₹16 Cr1.3%
Rest of the world₹12 Cr0.9%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹2804848
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-31Dividend (2.25/- per share)Final
dividend2026-07-31₹2.25 (112.5%)Final
forthcoming2026-07-30Board Meetings
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20261,98900901,998
20261860000186
20267070090716
Insider / Designated-Person Trades

13 recent disclosure(s)

Shouvanik ChatterjeeDisposal · 34,000
Anita NairAcquisition · 22,230
Sameer Narendrakumar LalDisposal · 60,000
SAMEER NARENDRA LALDisposal · 10,000
BINA SANJEEV PATIL RevisedDisposal · 2,000
BINA SANJEEV PATIL RevisedDisposal · 5,930
Substantial Acquisitions (SAST)

13 disclosure(s)

Release Of Encumbrances04/06/2025 ·
Release Of Pledge03/06/2025 ·
Market04/06/2025 · 2,44,75,402
Creation Of Encumbrance06/12/2024 ·
Release Of Encumbrances03/12/2024 ·
Release Of Encumbrances03/12/2024 ·
Company Information
Incorporated1998
ChairmanManish Gupta
AuditorDeloitte Haskins & Sells
Investor Email[email protected]
🌐 www.indegene.com

📍 Aspen Block G4 3rd Flr Manyata, Embassy Busi. Park Nagawara, Bengaluru, Karnataka, 560045

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search